Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.

Participants needed: 64
Trial details
Phase: Phase 2Age: 18-74Biological sex: AllType: InterventionalSponsor: Reunion Neuroscience IncUpdated: Jun 26, 2026Locations: 22
Eligibility criteria

Has Generalized Anxiety Disorder as defined by DSM-5-TR [+2]

Has a significant risk of suicide [+5]

Status: Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.

Participants needed: 100
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Reunion Neuroscience IncUpdated: Jun 3, 2026Locations: 30
Eligibility criteria

Has a ≥4 week history of AjD as defined by DSM-5-TR with either depressed mood,... [+5]

Has a significant risk of suicide [+5]